Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004267579 | SCV003899258 | uncertain significance | not specified | 2023-01-23 | criteria provided, single submitter | clinical testing | The c.713G>T (p.G238V) alteration is located in exon 4 (coding exon 4) of the PSG2 gene. This alteration results from a G to T substitution at nucleotide position 713, causing the glycine (G) at amino acid position 238 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |